Daily Courier: Single Column

Remember That DNA You Gave 23andMe?

The company is in trouble, and anyone who has spit into one of the company’s test tubes should be concerned. 23andMe is not doing well. Its stock is on the verge of being delisted. It shut down its in-house drug-development unit last month, only the latest in several rounds of layoffs. Last week, … Source
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.